BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8226564)

  • 1. Critical appraisal of immunization strategies for prevention of infection in the compromised host.
    Ambrosino DM; Molrine DC
    Hematol Oncol Clin North Am; 1993 Oct; 7(5):1027-50. PubMed ID: 8226564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical appraisal of antimicrobials for prevention of infections in immunocompromised hosts.
    Hathorn JW
    Hematol Oncol Clin North Am; 1993 Oct; 7(5):1051-99. PubMed ID: 8226565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approach to the immunocompromised host with infection in the intensive care unit.
    Linden PK
    Infect Dis Clin North Am; 2009 Sep; 23(3):535-56. PubMed ID: 19665082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantation.
    Ilan Y; Nagler A; Adler R; Naparstek E; Or R; Slavin S; Brautbar C; Shouval D
    Hepatology; 1993 Aug; 18(2):246-52. PubMed ID: 8340054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemophilus influenzae type b (HIB)-conjugate immunization before bone marrow harvest in autologous bone marrow transplantation.
    Molrine DC; Guinan EC; Antin JH; Wheeler C; Parsons SK; Weinstein HJ; McGarigle C; Blanding P; Phillips NR; Ciamarra A; George S; Ambrosino DM
    Bone Marrow Transplant; 1996 Jun; 17(6):1149-55. PubMed ID: 8807128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease.
    Anderson LD; Mori S; Mann S; Savary CA; Mullen CA
    Cancer Res; 2000 Oct; 60(20):5797-802. PubMed ID: 11059776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective antibody responses to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation.
    Antin JH; Guinan EC; Avigan D; Soiffer RJ; Joyce RM; Martin VJ; Molrine DC
    Biol Blood Marrow Transplant; 2005 Mar; 11(3):213-22. PubMed ID: 15744240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoptive transfer of immunity to hepatitis B virus in mice by bone marrow transplantation from immune donors.
    Shouval D; Adler R; Ilan Y
    Hepatology; 1993 Jun; 17(6):955-9. PubMed ID: 8514268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
    Zignol M; Peracchi M; Tridello G; Pillon M; Fregonese F; D'Elia R; Zanesco L; Cesaro S
    Cancer; 2004 Aug; 101(3):635-41. PubMed ID: 15274078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active and passive immunization against oral Candida albicans infection in a murine model.
    Farah CS; Ashman RB
    Oral Microbiol Immunol; 2005 Dec; 20(6):376-81. PubMed ID: 16238599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects for prevention of childhood infections by maternal immunization.
    Healy CM; Baker CJ
    Curr Opin Infect Dis; 2006 Jun; 19(3):271-6. PubMed ID: 16645489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of the solid organ transplant recipient.
    Sester M; Gärtner BC; Girndt M; Sester U
    Transplant Rev (Orlando); 2008 Oct; 22(4):274-84. PubMed ID: 18684606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effective analysis of hepatitis A prevention in Ireland.
    Rajan E; Shattock AG; Fielding JF
    Am J Gastroenterol; 2000 Jan; 95(1):223-6. PubMed ID: 10638588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized study on donor immunization with tetanus-diphtheria, Haemophilus influenzae type b and inactivated poliovirus vaccines to improve the recipient responses to the same vaccines after allogeneic bone marrow transplantation.
    Parkkali T; Käyhty H; Hovi T; Olander RM; Roivainen M; Volin L; Ruutu T; Lahdenkari M; Ruutu P
    Bone Marrow Transplant; 2007 Feb; 39(3):179-88. PubMed ID: 17211432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospects for development of vaccines against fungal diseases.
    Dan JM; Levitz SM
    Drug Resist Updat; 2006 Jun; 9(3):105-10. PubMed ID: 16820318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation.
    Vance E; George S; Guinan EC; Wheeler C; Antin JH; Ambrosino DM; Molrine DC
    Bone Marrow Transplant; 1998 Oct; 22(8):735-41. PubMed ID: 9827969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reimmunization after blood or marrow stem cell transplantation.
    Singhal S; Mehta J
    Bone Marrow Transplant; 1999 Apr; 23(7):637-46. PubMed ID: 10218839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection in the compromised host--an overview.
    Kottra CJ
    Heart Lung; 1983 Jan; 12(1):10-4. PubMed ID: 6549629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Post-vaccination immunity after allogenic and autologous bone marrow transplantation].
    Skovránková J
    Cas Lek Cesk; 1999 May; 138(10):298-300. PubMed ID: 10422338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.